These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36237253)

  • 1. Leptomeningeal metastasis from
    Zhang X; Shu X; Long B
    Transl Cancer Res; 2022 Sep; 11(9):3349-3356. PubMed ID: 36237253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy.
    Shi M; Sun D; Ma X; Liu J; Zhang Y; Liu T; Chen X; Mo S; Zhao Y; Zhang L
    Hum Vaccin Immunother; 2023 Dec; 19(3):2294579. PubMed ID: 38111107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review.
    Yang Y; Jiang J; Liu Y; Feng S; Bu H
    Medicine (Baltimore); 2024 Jun; 103(23):e37853. PubMed ID: 38847717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature.
    Pabon CM; Yeboa DN; O'Brien BJ; Majd NK; Wang C; Blum Murphy MA
    J Gastrointest Oncol; 2024 Jun; 15(3):1331-1340. PubMed ID: 38989402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptomeningeal metastasis of breast cancer during neo-adjuvant chemotherapy in a 38-year-old woman: a case report.
    Jin Y; Lu J; Zhang T; Yan S; Chen H; Zhang K; Chen Y; Zhou J
    AME Case Rep; 2024; 8():37. PubMed ID: 38711886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments.
    Zheng MM; Tu HY; Yang JJ; Zhang XC; Zhou Q; Xu CR; Jiang BY; Yang XN; Yang XR; Deng JY; Yang MY; Xu BF; Chen XM; Li YS; Wu YL
    Eur J Cancer; 2021 Jun; 150():23-30. PubMed ID: 33882375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative radiotherapy for leptomeningeal metastases after photon-based intensity-modulated radiotherapy in a nasopharyngeal cancer patient.
    Marlina YS; Novirianthy R; Beočanin A
    Narra J; 2023 Dec; 3(3):e266. PubMed ID: 38455636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival.
    Pan C; He N; Zhao M; Gu Y; Huang Z; Li W; Xia Y; Wu P
    Med Oncol; 2011 Dec; 28(4):1349-55. PubMed ID: 20820948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma.
    Pan C; Wu P; Yu J; Li W; Huang Z; He N; Wang J; Zhao M
    Int J Hyperthermia; 2011; 27(6):549-54. PubMed ID: 21846191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?
    Zhou X; Niu X; Liu P; Ou D; Zhu Y; Wang X
    Front Immunol; 2021; 12():762663. PubMed ID: 34777379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Leptomeningeal Metastases in a Patient with Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation.
    Niu H; Zhou J; Maan H; Markman M; Niu J
    Case Rep Oncol; 2017; 10(3):840-845. PubMed ID: 29070999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
    Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
    Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
    Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
    Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?
    Masterson L; Howard J; Gonzalez-Cruz J; Jackson C; Barnett C; Overton L; Liu H; Ladwa R; Simpson F; McGrath M; Wallwork B; Jones T; Ottensmeier C; Chua MLK; Perry C; Khanna R; Panizza B; Porceddu S; Lechner M
    Int J Cancer; 2020 Apr; 146(8):2305-2314. PubMed ID: 31950498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome.
    Chen XJ; Ren A; Zheng L; Zheng ED; Jiang T
    Front Immunol; 2021; 12():651086. PubMed ID: 34248939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Metastasis from Nasopharyngeal Carcinoma Treated with Stereotactic Radiosurgery.
    Park SH; Yoon SY; Park KS; Hwang JH; Hwang SK
    World Neurosurg; 2019 Jun; 126():160-163. PubMed ID: 30877007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year disease-free survival of Epstein-Barr virus-associated locoregionally advanced undifferentiated nasopharyngeal carcinoma patients treated with chemo-radiotherapy: a case report.
    Wang N; Wang H; Jiang H; Bi Y; Zhao Y; He X; Cao F; Yuan Y
    Ann Palliat Med; 2022 Mar; 11(3):1147-1152. PubMed ID: 35365045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial data of Anti-PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A review.
    Adkins DR; Haddad RI
    Cancer Treat Rev; 2022 Sep; 109():102428. PubMed ID: 35753157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dural and Multiple Brain Metastases From Basaloid Nasopharyngeal Carcinoma: Case Report and Literature Review.
    Geng X; Hao F; Han G; Zhang Y; Qin P
    Front Oncol; 2021; 11():665652. PubMed ID: 34336659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases.
    Qiao M; Zhou F; Hou L; Li X; Zhao C; Jiang T; Gao G; Su C; Wu C; Ren S; Zhou C
    Ann Transl Med; 2021 Jan; 9(1):34. PubMed ID: 33553327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.